PRIME MEDICINE INC (PRME) Stock Income Statement
USA - NASDAQ:PRME - US74168J1016 - Common Stock
5.39 USD
+0.4 (+8.02%)
5.4 USD
+0.01 (+0.19%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.96M | 2.98M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 209.18M | 205.45M | 204.79M | 116.54M | 84.47M | |||
| Research and Development | 156.38M | 155.29M | 147.91M | 86.73M | 70.55M | |||
| Selling, General, and Administrative Expenses | 52.80M | 50.16M | 43.39M | 29.82M | 13.92M | |||
| Operating Income | -204.22M | -202.47M | -204.79M | -116.54M | -84.47M | |||
| Interest Income/Expense | 4.93M | 6.54M | -2.38M | -8.13M | -390.00K | |||
| Other Income/Expense | 15.00K | 41.00K | 8.76M | 1.90M | -80.99M | |||
| Income Before Taxes | -199.28M | -195.88M | -198.41M | -122.77M | -165.85M | |||
| Income Tax | 0.00 | 0.00 | -279.00K | -950.00K | -490.00K | |||
| Net Income | -199.28M | -195.88M | -198.13M | -142.01M | -184.12M | |||
| EBITDA | -197.38M | -196.34M | -200.14M | -114.32M | -83.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.56 | -1.65 | -2.18 | -1.46 | -1.95 | |||
| Non GAAP EPS | -1.56 | -1.65 | -2.18 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -4016.83% | -6566.61% | N/A | N/A | N/A | |||
| Operating Profit Margin | -4116.57% | -6787.36% | N/A | N/A | N/A | |||
All data in USD